Sustained spread among cows would give the virus more chances to become more transmissible among humans. Experts believe pasteurization, in which milk is briefly heated, should kill the virus.
Infectious Diseases
— DRUG MONOGRAPHS BY SUBSECTION —
News and Features
Patients are presenting with headache, hearing or vision issues.
The approval was based on data from an open-label clinical trial that included 33 virologically-suppressed pregnant adults.
Up to 40% of patients hospitalized with urinary tract infection unnecessarily receive extended-spectrum antibiotics.
Consumers of seafood purchased in a local Northeastern US market may be exposed to potentially risky PFAS concentrations.
Despite patient beliefs, no impact seen on severity, duration of cough.
The approval was based on data from three phase 3 trials which compared the efficacy of different dosing regimens of pivmecillinam to placebo, to another oral antibacterial drug, and to ibuprofen.
Forty-one point five percent of difficult-to-treat resistance episodes were treated exclusively with traditional agents.
HealthDay News — Measles infections continue to spread across the country, with 125 cases now reported in 18 states, new US government data shows. That is more cases than were reported in all of 2022, the most recent annual peak for measles infections, the US Centers of Disease Control and Prevention reported Friday. So far this…
Children aged 24 to 59 months were 4.86 times as likely to be hospitalized in 2022 vs 2015 to 2019.
About 88% of syphilis cases in newborns could be prevented with timely screening and treatment.
17.4 percent reduction seen in empiric extended-spectrum days of therapy, with no increase in safety outcomes.
However, study reveals important barriers in community-based Helicobacter pylori eradication
A regulatory decision is expected on February 14, 2025.
DefenCath is a combination of taurolidine, a thiadiazinane antimicrobial, and heparin, an anticoagulant
Combining self-sampling with phone-based patient navigation further increases screening participation.
The increase in cases in 2024 suggests that additional efforts are needed to encourage MMR vaccination.
Asthma treatment gains approval for severe cases in pediatrics; Dovato gains expanded indication; Decision taken to remove ALS drug from market; Complete Response Letter issued for apomorphine device; At-home Mpox test kit made available.
The table below is a review of notable updates that occurred in March 2024 for investigational products in development.
- Loading...
